Cargando…

Intercalated low doses of antimonials for disseminated cutaneous leishmaniasis caused by Leishmania guyanensis: A successful approach in Amazonas, Brazil

Detalles Bibliográficos
Autores principales:	Monçale Campos, Aline Grasielli, Oliveira, Louise Makarem, Hollanda, Laísa Ezaguy de, Valle, Valeska Albuquerque Francesconi do, Valle, Fábio Francesconi do
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232638/ https://www.ncbi.nlm.nih.gov/pubmed/30456283 http://dx.doi.org/10.1016/j.jdcr.2018.07.014

Ejemplares similares

Squamous cell carcinoma arising from a chromomycosis lesion caused by Rhinocladiella aquaspersa with postsurgical recurrence of chromomycosis
por: Monçale Campos, Aline Grasielli, et al.
Publicado: (2018)

Failure of fluconazole in treating cutaneous leishmaniasis caused by Leishmania guyanensis in the Brazilian Amazon: An open, nonrandomized phase 2 trial
por: Francesconi, Valeska Albuquerque, et al.
Publicado: (2018)

Polymorphisms in the TOLLIP Gene Influence Susceptibility to Cutaneous Leishmaniasis Caused by Leishmania guyanensis in the Amazonas State of Brazil
por: de Araujo, Felipe Jules, et al.
Publicado: (2015)

Mutilating localized cutaneous leishmaniasis caused by Leishmania guyanensis()
por: Silva, Dina Fabrício da, et al.
Publicado: (2023)

Single nucleotide polymorphisms of the genes IL-2, IL-2RB, and JAK3 in patients with cutaneous leishmaniasis caused by Leishmania (V.) guyanensis in Manaus, Amazonas, Brazil
por: de Araújo Santos, Felipe Jules, et al.
Publicado: (2019)

TREM1 rs2234237 (Thr25Ser) Polymorphism in Patients with Cutaneous Leishmaniasis Caused by Leishmania guyanensis: A Case-Control Study in the State of Amazonas, Brazil
por: do Espírito Santo Júnior, José, et al.
Publicado: (2021)

Mucosal Leishmaniasis Caused by Leishmania (Viannia) braziliensis and Leishmania (Viannia) guyanensis in the Brazilian Amazon
por: Guerra, Jorge Augusto de Oliveira, et al.
Publicado: (2011)

Leishmania (Viannia) guyanensis Causing Localized Cutaneous Leishmaniasis in a Traveler
por: Motie, Ian K, et al.
Publicado: (2022)

Distinct plasma chemokines and cytokines signatures in Leishmania guyanensis-infected patients with cutaneous leishmaniasis
por: de Mesquita, Tirza Gabrielle Ramos, et al.
Publicado: (2022)

Variants of NOD2 in Leishmania guyanensis-infected patients with cutaneous leishmaniasis and correlations with plasma circulating pro-inflammatory cytokines
por: de Mesquita, Tirza Gabrielle Ramos, et al.
Publicado: (2023)

Leishmania (Viannia) guyanensis Infection, Austria
por: Poeppl, Wolfgang, et al.
Publicado: (2012)

Intrachromosomal Amplification, Locus Deletion and Point Mutation in the Aquaglyceroporin AQP1 Gene in Antimony Resistant Leishmania (Viannia) guyanensis
por: Monte-Neto, Rubens, et al.
Publicado: (2015)

Characterization of Leishmania spp. causing cutaneous leishmaniasis in Manaus, Amazonas, Brazil
por: Camara Coelho, Leila Ines, et al.
Publicado: (2010)

Filling the gaps in Leishmania naiffi and Leishmania guyanensis genome plasticity
por: Patiño, Luz H, et al.
Publicado: (2021)

First Report of Canine Infection by Leishmania (Viannia) guyanensis in the Brazilian Amazon
por: Santos, Francisco J. A., et al.
Publicado: (2020)

Insights from Leishmania (Viannia) guyanensis in vitro behavior and intercellular communication
por: Pereira, Luiza O. R., et al.
Publicado: (2021)

Insights on Host–Parasite Immunomodulation Mediated by Extracellular Vesicles of Cutaneous Leishmania shawi and Leishmania guyanensis
por: Weber, Juliana Inês, et al.
Publicado: (2023)

Variants of CARD8 in Leishmania guyanensis-cutaneous leishmaniasis and influence of the variants genotypes on circulating plasma cytokines IL-1β, TNFα and IL-8
por: Sequera, Héctor David Graterol, et al.
Publicado: (2023)

Immuno-pharmacokinetics of Meglumine Antimoniate in Patients With Cutaneous Leishmaniasis Caused by Leishmania (Viannia)
por: Gómez, María Adelaida, et al.
Publicado: (2020)

Molecular tools confirm natural Leishmania (Viannia) guyanensis/L. (V.) shawi hybrids causing cutaneous leishmaniasis in the Amazon region of Brazil
por: Lima, Ana Carolina S., et al.
Publicado: (2021)

Leishmania naiffi and Leishmania guyanensis reference genomes highlight genome structure and gene evolution in the Viannia subgenus
por: Coughlan, Simone, et al.
Publicado: (2018)

Leishmania Sores and Antimony
por: Narasimhan, N. S.
Publicado: (1918)

Variants of MIRNA146A rs2910164 and MIRNA499 rs3746444 are associated with the development of cutaneous leishmaniasis caused by Leishmania guyanensis and with plasma chemokine IL-8
por: de Mesquita, Tirza Gabrielle Ramos, et al.
Publicado: (2021)

Identification and Biological Characterization of Leishmania (Viannia) guyanensis Isolated from a Patient with Tegumentary Leishmaniasis in Goiás, a Nonendemic Area for This Species in Brazil
por: Pires, Alause da Silva, et al.
Publicado: (2015)

Distinct Macrophage Fates after in vitro Infection with Different Species of Leishmania: Induction of Apoptosis by Leishmania (Leishmania) amazonensis, but Not by Leishmania (Viannia) guyanensis
por: DaMata, Jarina Pena, et al.
Publicado: (2015)

A fine mapping of single nucleotide variants and haplotype analysis of IL13 gene in patients with Leishmania guyanensis-cutaneous leishmaniasis and plasma cytokines IL-4, IL-5, and IL-13
por: Junior, José do Espírito Santo, et al.
Publicado: (2023)

Phenotypic characterization of Leishmania spp. causing cutaneous leishmaniasis in the lower Amazon region, western Pará state, Brazil, reveals a putative hybrid parasite, Leishmania (Viannia) guyanensis × Leishmania (Viannia) shawi shawi
por: Jennings, Yara Lins, et al.
Publicado: (2014)

Lutzomyia umbratilis, the Main Vector of Leishmania guyanensis, Represents a Novel Species Complex?
por: Scarpassa, Vera Margarete, et al.
Publicado: (2012)

Leishmania guyanensis parasites block the activation of the inflammasome by inhibiting maturation of IL-1β
por: Hartley, Mary-Anne, et al.
Publicado: (2018)

Leishmania guyanensis suppressed inducible nitric oxide synthase provoked by its viral endosymbiont
por: Kopelyanskiy, Dmitry, et al.
Publicado: (2022)

Recurrent pruritic polymorphic lesions associated with weight loss
por: Záu, Aline Sales Mendes, et al.
Publicado: (2022)

Biodistribution of meglumine antimoniate in healthy and Leishmania (Leishmania) infantum chagasi-infected BALB/c mice
por: Borborema, Samanta Etel Treiger, et al.
Publicado: (2013)

Lobomycosis: epidemiology, clinical presentation, and management options
por: Francesconi, Valeska Albuquerque, et al.
Publicado: (2014)

Lutzomyia umbratilis from an area south of the Negro River is refractory to in vitro interaction with Leishmania guyanensis
por: Soares, Rodrigo Pedro, et al.
Publicado: (2018)

Disseminated Cutaneous Leishmaniasis in a Patient Infected by Leishmania panamensis
por: Cataño, Juan Carlos, et al.
Publicado: (2019)

Disseminated cutaneous leishmaniasis caused by Leishmania braziliensis in Southern Brazil
por: Membrive, Norberto Assis, et al.
Publicado: (2017)

Metabolite Biomarkers of Leishmania Antimony Resistance
por: Gutierrez Guarnizo, Sneider Alexander, et al.
Publicado: (2021)

Phenotypic and genotypic variations among three allopatric populations of Lutzomyia umbratilis, main vector of Leishmania guyanensis
por: de Souza Freitas, Moises Thiago, et al.
Publicado: (2015)

Multiple evolutionary lineages for the main vector of Leishmania guyanensis, Lutzomyia umbratilis (Diptera: Psychodidae), in the Brazilian Amazon
por: Scarpassa, Vera Margarete, et al.
Publicado: (2021)

Gene Expression Profiling and Molecular Characterization of Antimony Resistance in Leishmania amazonensis
por: do Monte-Neto, Rubens L., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_vc2jofe09n2f0si2kcf2gis8g3